Clin2
NCT07445464Worth exploringNot yet recruiting

Study of ASP-001 in healthy volunteers

Pharmacokinetic Analysis

Treatments studied

This study tests how a new medicine, ASP-001, is processed in the body of healthy volunteers. It helps find the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Be between 18 and 65 years old
  • Be a non-smoker (no nicotine for at least 6 months)
  • Weigh at least 45 kg (99 lbs) and have a BMI between 18.5 and 32
  • Be generally healthy with no major medical problems
  • Not be pregnant or breastfeeding, and if able to become pregnant, use birth control
  • Avoid certain medications and supplements for a week or more before the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07773129Not yet recruiting· Phase 1
How the study drug ASP3082 moves through the body

This study is for healthy men to see how the body processes an investigational drug called ASP3082. It is a first-in-human study, meaning it's one of the first times the drug is given to people, and the results will guide future research.

NCT06995820Recruiting· Phase 1
Safety study of AZD1613 in healthy volunteers

This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.

Glendale, California
NCT06847698Not yet recruiting· Phase 1
First-in-human study of AVR-48 in healthy volunteers

This early-stage study tests an investigational drug called AVR-48 in healthy volunteers. You will receive either a single dose or multiple doses to see how the drug is absorbed, processed, and tolerated by your body.

Austin, Texas
NCT07254481Recruiting· Phase 1
Safety study of VB19055 in healthy volunteers

This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.

Hangzhou
NCT07623057Recruiting· Phase 1
Safety Study of FB102 in Healthy Adults

This early-stage study tests whether a new drug called FB102 is safe in people without serious health conditions. Researchers will monitor volunteers closely to understand how the body handles the drug.

Eastwood, Queensland
NCT06867796Not yet recruiting· Phase 1
Safety study of TL-001 in healthy adults

This trial tests a new drug, TL-001, in healthy volunteers to see if it is safe and how the body processes it. You may join if you are a healthy adult between 18 and 55.

Hear when a new Pharmacokinetic Analysis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.